Of note, the authors of a recent report showed that FOXM1 and its regulated target genes AURKA, AURKB and BIRC5/survivin display the greatest prognostic discrimination among a panel of genes analyzed for overall survival of patients with ER+ breast cancer and an intermediate Oncotype DX 21-gene recurrence score. The gene discussed is BIRC5; the disease is breast carcinoma.